Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at PLN 551.7B, ahead of Pfizer (PLN 488.1B) and Johnson & Johnson (PLN 473.2B). Figures as of 18 Nov 2026, 15:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbViePLN 551.7B
- Median
- PLN 8.4B
- Combined market value
- PLN 20.44T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | PLN 551.7B | PLN 2.05T | PLN 1,158.94 | 1.58% down | 26% up | ||
| 2 | PfizerPFE · Health Care | PLN 488.1B | PLN 645.9B | PLN 113.32 | 1.02% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | PLN 473.2B | PLN 2.66T | PLN 1,105.38 | 1.37% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | PLN 345.6B | PLN 4.98T | PLN 5,587.83 | 1.84% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | PLN 338.6B | PLN 1.38T | PLN 561.39 | 2.63% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | PLN 287.7B | PLN 493.2B | PLN 241.29 | 2.20% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | PLN 262.8B | PLN 1.12T | PLN 719.44 | 1.85% down | 2% up | ||
| 8 | NovartisNVS · Health Care | PLN 259B | PLN 1.19T | PLN 629.32 | 1.66% down | 25% up | ||
| 9 | SanofiSNY · Health Care | PLN 245.8B | PLN 456.6B | PLN 190.13 | 0.53% down | 4% down | ||
| 10 | GSKGSK · Health Care | PLN 241.1B | PLN 394B | PLN 196.57 | 0.73% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | PLN 208.2B | PLN 702.9B | PLN 159.49 | 2.56% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | PLN 203.5B | PLN 274.4B | PLN 85.87 | 1.32% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | PLN 136.5B | PLN 723.4B | PLN 417.69 | 0.81% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 132B | PLN 199.3B | PLN 170.77 | 0.36% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | PLN 90.4B | PLN 95.5B | PLN 83.30 | 1.30% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | PLN 54B | PLN 23.3B | PLN 34.28 | 1.22% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | PLN 48.8B | PLN 136.9B | PLN 336.82 | 0.33% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | PLN 39.8B | PLN 158.5B | PLN 275.69 | 0.18% down | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | PLN 37.4B | PLN 397.8B | PLN 3,845.63 | 0.15% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 29.5B | PLN 62.7B | PLN 976.69 | 0.90% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | PLN 28.3B | PLN 127.7B | PLN 207.08 | 0.89% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | PLN 28.1B | PLN 543.1B | PLN 2,142.23 | 0.28% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | PLN 27.4B | PLN 52.9B | PLN 105.92 | 1.90% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | PLN 16.8B | PLN 82.6B | PLN 616.73 | 2.01% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | PLN 15.4B | PLN 185.8B | PLN 1,626.52 | 2.13% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.8B | PLN 30.3B | PLN 86.86 | 2.27% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | PLN 12.5B | PLN 20.3B | PLN 243.02 | 0.12% up | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | PLN 12.2B | PLN 18.2B | PLN 109.46 | 0.96% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | PLN 12.1B | PLN 60.9B | PLN 312.43 | 1.16% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 8.5B | PLN 50.3B | PLN 60.28 | 1.35% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | PLN 8.4B | PLN 28.8B | PLN 206.70 | 0.48% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | PLN 6.5B | PLN 71.5B | PLN 1,089.85 | 0.07% down | 28% up | ||
| 33 | InsmedINSM · Health Care | PLN 6.1B | PLN 105.5B | PLN 481.11 | 1.83% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | PLN 6.1B | PLN 46.8B | PLN 241.41 | 2.60% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.5B | PLN 24.7B | PLN 174.99 | 1.22% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | PLN 3.2B | PLN 98.1B | PLN 2,304.20 | 1.90% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | PLN 2.9B | PLN 12.7B | PLN 65.31 | 0.81% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | PLN 2.7B | PLN 31.4B | PLN 187.12 | 2.38% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.6B | PLN 38.7B | PLN 1,664.78 | 1.90% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | PLN 2.4B | PLN 28B | PLN 532.88 | 2.53% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | PLN 2.2B | PLN 24B | PLN 1,199.14 | 1.49% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 24B | PLN 367.48 | 0.62% down | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 19.4B | PLN 201.78 | 1.81% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | PLN 1.7B | PLN 113.6B | PLN 156.80 | 0.72% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | PLN 1.7B | PLN 38.8B | PLN 256.53 | 1.72% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | PLN 1.2B | PLN 19.9B | PLN 114.41 | 2.15% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 845.2M | PLN 32.5B | PLN 468.18 | 0.16% down | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 788.3M | PLN 30.3B | PLN 385.82 | 0.87% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | PLN 759.4M | PLN 30.1B | PLN 274.79 | 2.48% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | PLN 576.2M | PLN 29.5B | PLN 337.18 | 2.13% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | PLN 433.4M | PLN 15.7B | PLN 114.85 | 2.79% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | PLN 371.3M | PLN 34.8B | PLN 43.51 | 1.41% up | 36% down | ||
| 53 | ErascaERAS · Health Care | PLN 285.5M | PLN 18.6B | PLN 52.92 | 5.26% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | PLN 251.5M | PLN 36.4B | PLN 383.21 | 1.58% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | PLN 240.4M | PLN 34.4B | PLN 1,229.52 | 0.22% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | PLN 215.1M | PLN 32.7B | PLN 501.15 | 0.04% down | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | PLN 150.9M | PLN 19.6B | PLN 348.20 | 0.45% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | PLN 122M | PLN 18B | PLN 164.12 | 2.93% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | PLN 67.1M | PLN 26.3B | PLN 387.51 | 0.04% up | 241% up | ||
| 60 | Belite BioBLTE · Health Care | PLN 40.5M | PLN 25.9B | PLN 637.28 | 0.48% up | 31% up | ||
| 61 | VeradermicsMANE · Health Care | PLN 36.8M | PLN 21B | PLN 496.71 | 1.69% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0214 PLN).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (PLN 551.7B), Pfizer (PLN 488.1B) and Johnson & Johnson (PLN 473.2B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 15:56 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of PLN 20.44T as of 18 Nov 2026, 15:56 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.